Literature DB >> 1581538

Hepatic microsomal metabolism of the anthelmintic benzimidazole fenbendazole: enhanced inhibition of cytochrome P450 reactions by oxidized metabolites of the drug.

M Murray1, A M Hudson, V Yassa.   

Abstract

Potentiation of the anthelmintic action of benzimidazole carbamates, such as fenbendazole [methyl 5(6)-(phenylthio)-1H-benzimidazol-2-ylcarbamate], has been noted during concurrent administration of benzimidazoles that possess no intrinsic anthelmintic activity. This study investigated the possibility that inhibition of P450 enzymes by fenbendazole and its metabolites could play a role in the potentiation phenomenon. Fenbendazole underwent P450-mediated oxidation in microsomes from untreated rat liver to the sulfoxide and (4'-hydroxyphenyl)thio metabolites [2.92 and 2.87 nmol/(mg of protein.h)]. Pretreatment of rats with phenobarbital or dexamethasone enhanced sulfoxidation by 1.9- and 2.9-fold, respectively. 4'-Hydroxylation was increased slightly (by 28%) by phenobarbital and decreased slightly (by 41%) by dexamethasone. Induction also promoted further metabolism of the sulfoxide to fenbendazole sulfone. Immunoinhibition and chemical inhibition studies suggested that P450 3A proteins and the flavin-containing monooxygenase are involved in sulfoxide and sulfone formation whereas 4'-hydroxylation involved the P450s 2C11, 2C6, and 2B1, depending on the type of induction. In untreated rat liver, the sulfoxide and (4'-hydroxyphenyl)thio metabolites of fenbendazole were relatively potent inhibitors of P450-mediated androstenedione 16 alpha-, 16 beta-, and 6 beta-hydroxylation (IC50 values of 42, 36, and 74 microM, respectively); 7 alpha-hydroxylase activity was uninhibited. In contrast, fenbendazole and its sulfone metabolite were not inhibitors of these reactions. Mixed-function oxidase activities in phenobarbital-induced rat hepatic microsomes were refractory to inhibition by most compounds, but P450 1A1 mediated activities in microsomes from beta-naphthoflavone-induced rat liver were quite susceptible to inhibition by fenbendazole sulfoxide. Studies with two analogous sulfoxides yielded similar findings.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1581538     DOI: 10.1021/tx00025a010

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  7 in total

1.  Population Pharmacokinetic Model of Oxfendazole and Metabolites in Healthy Adults following Single Ascending Doses.

Authors:  Thanh Bach; Daryl J Murry; Larissa V Stebounova; Gregory Deye; Patricia Winokur; Guohua An
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

2.  Differential regulation of endobiotic-oxidizing cytochromes P450 in vitamin A-deficient male rat liver.

Authors:  M Murray; R M Sefton; K D Croft; A M Butler
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems.

Authors:  Zhexue Wu; Doohyun Lee; Jeongmin Joo; Jung-Hoon Shin; Wonku Kang; Sangtaek Oh; Do Yup Lee; Su-Jun Lee; Sung Su Yea; Hye Suk Lee; Taeho Lee; Kwang-Hyeon Liu
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

4.  Exacerbation of acetaminophen hepatotoxicity by the anthelmentic drug fenbendazole.

Authors:  Carol R Gardner; Vladimir Mishin; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2011-11-01       Impact factor: 4.849

5.  Upregulation of cytochromes P450 2B in rat liver by orphenadrine.

Authors:  Michael Murray; Eva Fiala-Beer; Dylan Sutton
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

6.  Differential Gene Expression across Breed and Sex in Commercial Pigs Administered Fenbendazole and Flunixin Meglumine.

Authors:  Jeremy T Howard; Audrey T O'Nan; Christian Maltecca; Ronald E Baynes; Melissa S Ashwell
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

7.  Comparative plasma exposure of albendazole after administration of rapidly disintegrating tablets in dogs.

Authors:  Silvina G Castro; Alicia Dib; Gonzalo Suarez; Daniel Allemandi; Carlos Lanusse; Sergio Sanchez Bruni; Santiago D Palma
Journal:  Biomed Res Int       Date:  2013-08-25       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.